ScienceneuroscienceBrain-Computer Interfaces
Bryan Johnson Livestreams Psychedelic Trip for Longevity Research
In a move that blurred the lines between Silicon Valley spectacle and serious biohacking, tech entrepreneur Bryan Johnson recently livestreamed a psilocybin trip, a controversial experiment squarely within his multi-million-dollar quest to reverse human aging. The event, which notably featured cameos from musician Grimes and Salesforce co-founder Marc Benioff, wasn't merely a voyeuristic dive into altered consciousness; it was a calculated, if provocative, data-gathering mission for Johnsonâs ambitious Project Blueprint.This initiative, which famously involves a regimented diet, hundreds of daily supplements, and constant physiological monitoring, now expands into the neurochemical frontier, positing that controlled psychedelic experiences could be a next-generation tool for cognitive optimization and cellular repair. Johnsonâs approach mirrors a growing trend within the longevity sphere, where pioneers are moving beyond traditional supplements and caloric restriction to explore epigenetic reprogramming and, as seen here, psychoactive compounds believed to promote neural plasticity and reduce inflammatory markers linked to age-related decline.Critics, however, question the scientific rigor of a publicized trip, arguing that the spectacle risks overshadowing the nuanced, early-stage research into psychedelics like psilocybin for conditions such as treatment-resistant depression and end-of-life anxiety, which is conducted under strict clinical protocols. The involvement of high-profile figures like Benioff, a significant investor in longevity startups, and Grimes, who has her own transhumanist artistic leanings, underscores how this pursuit has become the new pet project for the tech elite, merging a hacker ethos with a profound fear of mortality.From a biotech perspective, Johnsonâs experiment, while unorthodox, forces a conversation about the regulatory and ethical frameworks for biohacking, where individuals act as their own test subjects outside institutional oversight. The potential consequences are significant: if anecdotally successful, such public demos could accelerate mainstream interest and investment in psychedelic longevity research, but they also risk creating a dangerous precedent for self-experimentation and commodifying a deeply personal therapeutic process.Historically, the quest for immortality has driven alchemy and fringe science; today, itâs powered by venture capital and quantified self-tracking. Johnsonâs livestream may one day be viewed as a pivotal, if awkward, moment in that continuumâa public gambit that challenged medical conservatism and pushed the conversation about human enhancement into uncomfortably intimate territory, for better or worse.
#featured
#Bryan Johnson
#psychedelics
#longevity research
#live stream
#Grimes
#Marc Benioff
#biohacking